Tatsutani Kristine N 4
4 · Zeltiq Aesthetics Inc · Filed Apr 24, 2013
Insider Transaction Report
Form 4
Tatsutani Kristine N
CTO and VP
Transactions
- Exercise/Conversion
Common Stock
2013-04-22$2.83/sh+5,696$16,120→ 37,544 total - Sale
Common Stock
2013-04-22$4.60/sh−1,079$4,963→ 30,769 total - Sale
Common Stock
2013-04-22$4.60/sh−5,696$26,202→ 31,848 total - Exercise/Conversion
Common Stock
2013-04-23$2.83/sh+12,119$34,297→ 42,888 total - Sale
Common Stock
2013-04-23$4.61/sh−12,119$55,869→ 30,769 total - Exercise/Conversion
Stock Option (Right to buy)
2013-04-22−5,696→ 94,429 totalExercise: $2.83Exp: 2021-05-17→ Common Stock (5,696 underlying) - Exercise/Conversion
Stock Option (Right to buy)
2012-04-23−12,119→ 82,310 totalExercise: $2.83Exp: 2021-05-17→ Common Stock (12,119 underlying)
Footnotes (4)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on December 13, 2012.
- [F2]The price reported in Column for is an average price. These shares were sold in multiple transactions at prices ranging from $4.60-$4.74 inclusive. The reporting person undertakes to provide to ZELTIQ Aesthetics, Inc., any security holder of ZELTIQ Aesthetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
- [F3]The initial RSU for 7,692 vests in four equal installments, of which the first vested on February 17, 2013.
- [F4]25% of the granted 117,696 shares became exercisable on 5/18/2012. The remaining vest in a series of 36 equal monthly installments; provided the Reporting Person continues to provide service to ZELTIQ Aesthetics, Inc.